Literature DB >> 158764

Trophoblast modulation of maternal allogeneic recognition.

J A McIntyre, W P Faulk.   

Abstract

Human syncytiotrophoblast cell membranes prepared by differential ultracentrifugation were extracted with 3 M KCl, solubilized in 1% deoxycholate, and chromatographically separated into two peaks by passage through a column of Bio-Gel P-200. Previous reports from this laboratory have shown that the first peak (PI) is serologically the same as a group of trophoblast membrane antigens tentatively designated as TA1. Microgram amounts of P1 protein were found to completely inhibit the mixed lymphocyte culture (MLC) reaction but had no suppressive effect on lymphocyte responses to the lectins phytohemagglutinin or pokeweed mitogen. Control P1 membrane fractions identically prepared from human erythrocytes and liver powder had no inhibitory effects on either MLC reactions or lymphocyte responses to mitogens. Dose response experiments with P1 from 10 different placentae showed total inhibition of MLC by all preparations when used between 25 and 50 microgram/0.2-ml MLC mixture, but some P1 fractions inhibited significantly at much lower concentrations. Timed experiments revealed that MLC suppression was maximal when P1 was added within 12 hr after culture initiation and that no effect could be found with addition after 48 hr. We have previously shown that TA1 is a lymphocyte product of allogeneic responses, and the present results indicate that P1 proteins are themselves involved in the biology of lymphocyte responses to allogeneic cells. Pregnancy is one of the few natural circumstances in which a mixing of allogeneic cells occurs in vivo, and the presence of P1 proteins at the operational interface in the host-parasite relationship of human pregnancy suggests that this trophoblast membrane constituent is involved in the modulation of maternal allogeneic responses.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 158764      PMCID: PMC383970          DOI: 10.1073/pnas.76.8.4029

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

Review 1.  Structure and function of the amnion.

Authors:  A D Hoyes
Journal:  Obstet Gynecol Annu       Date:  1975

2.  Antigenicity of trophoblast and possible antigen-masking effects during pregnancy.

Authors:  P V Taylor; K W Hancock
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

3.  Human leukocyte antigens (HLA).

Authors:  J A McIntyre; R E Turner; E C LeRoy
Journal:  South Med J       Date:  1978-10       Impact factor: 0.954

4.  Suppression of mixed lymphocyte cultures by antibodies against human trophoblast membrane antigens.

Authors:  J A McIntyre; W P Faulk
Journal:  Transplant Proc       Date:  1978-12       Impact factor: 1.066

5.  Anti-HLA, anti-human "Ia-like" and MLC blocking activity of human placental IgG.

Authors:  M Jeannet; C Werner; E Ramirez; P Vassalli; W P Faulk
Journal:  Transplant Proc       Date:  1977-06       Impact factor: 1.066

Review 6.  Biological and clinical significance of differences between RBC membrane (Rh) and non-membrane (ABH, MN, P) antigenic sites: illegitimate ABO, M-N (T), P (Tja) antigens in malignancy.

Authors:  P Levine
Journal:  Rev Fr Transfus Immunohematol       Date:  1976-03

7.  Antigens of human trophoblasts: a working hypothesis for their role in normal and abnormal pregnancies.

Authors:  W P Faulk; A Temple; R E Lovins; N Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

8.  Distribution of MHC antigens in human placental chorionic villi.

Authors:  W P Faulk; A R Sanderson; A Temple
Journal:  Transplant Proc       Date:  1977-06       Impact factor: 1.066

9.  Trophoblast transferrin and transferrin receptors in the host--parasite relationship of human pregnancy.

Authors:  W P Faulk; G M Galbraith
Journal:  Proc R Soc Lond B Biol Sci       Date:  1979-03-26

10.  Antigens of human trophoblast. Effects of heterologous anti-trophoblast sera on lymphocyte responses in vitro.

Authors:  J A McIntyre; W P Faulk
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

View more
  7 in total

1.  Recurrent miscarriage.

Authors:  L Regan
Journal:  BMJ       Date:  1991-03-09

2.  Monoclonal antibodies to human syncytiotrophoblast.

Authors:  C A Sunderland; C W Redman; G M Stirrat
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

Review 3.  Synergies of Extracellular Vesicles and Microchimerism in Promoting Immunotolerance During Pregnancy.

Authors:  José M Murrieta-Coxca; Paulina Fuentes-Zacarias; Stephanie Ospina-Prieto; Udo R Markert; Diana M Morales-Prieto
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

4.  Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi.

Authors:  D Sinha; M Wells; W P Faulk
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

5.  Identification of human trophoblast membrane antigens in maternal blood during pregnancy.

Authors:  M J O'Sullivan; J A McIntyre; M Prior; G Warriner; W P Faulk
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

Review 6.  To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

Authors:  Elizabeth A Bonney; Stephen A Brown
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

Review 7.  Reproductive immunology: biomarkers of compromised pregnancies.

Authors:  W P Faulk; C B Coulam; J A McIntyre
Journal:  Environ Health Perspect       Date:  1987-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.